Therapeutic Strategies in Cancer Biology and Pathology

個数:
電子版価格
¥22,588
  • 電子版あり

Therapeutic Strategies in Cancer Biology and Pathology

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • ≪洋書のご注文について≫ 「海外取次在庫あり」「国内在庫僅少」および「国内仕入れ先からお取り寄せいたします」表示の商品でもクリスマス前(12/20~12/25)および年末年始までにお届けできないことがございます。あらかじめご了承ください。

  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 310 p.
  • 言語 ENG
  • 商品コード 9780124165700
  • DDC分類 616.994

Full Description

Currently, intensive effort is being directed toward the identification of molecular targets that can provide approaches to the development of novel therapeutic strategies in cancer management. This book focuses on metastasis-associated genes, metastasis promoter and suppressor genes, which relate specifically to behavioral alterations of cancer cells in epithelial mesenchymal transition, cancer stem cell maintenance and propagation, and to the acquisition of invasive and metastasis faculty. The function of these genes has implications for cell cycle regulation and cell proliferation and so constitute an essential element in cancer growth and dissemination. The emphasis in this book is on how appropriate these genes are as molecular targets and how practicable are the constituents of their signal transduction systems as potential candidates and how accessible they are to targeted therapy. Written in a straightforward and clear style with background information supporting the new research, this book will be useful for students and researchers in cancer therapies.

Contents

Introduction

Part I: RNA interference in genetic regulation1. The biogenesis and functions of microRNAs 2. Association of miRNAs with pathogenesis3. Are miRNAs suitable targets for cancer therapy?

Part II: EMT associated gene targeting4. Hedgehog signalling in EMT5. Targeted inhibition of Hh, Wnt, TGF-β signalling complex6. Encountering aberrant Wnt signalling7. Therapeutic targeting of TGF-β signalling8. EGFR signalling in EMT

Part III: Therapeutic deployment of tumour and metastasis promoter gene function9. S100A4 as a potential target10. MTAs in cancer invasion and metastasis

Part IV: Genetic determinants of tumour and metastasis suppression 11. Metastasis suppressor gene nm23 and manipulation of its expression12. The metastasis suppressor KiSS-1 gene13. KAI1 (CD82) suppresses metastasis, cell proliferation and invasion14. 14-3-3 proteins in normal and tumour cell biology15. Suppressor function of NDRG1 (N-myc downstream-regulated gene-1) 16. The ING (inhibitor of growth) suppressor gene17. The BRCA1 and BRCA2 suppressor genes18. BRMS1 (breast cancer metastasis suppressor 1) gene 19. Maspin, a postulated tumour suppressor 20. EPB41L3 and CADM1 tumour suppressor function

Part V: Signalling and transcription regulators as prospective candidates21. Is MKK a metastasis suppressor?22. RKIP (The Raf kinase inhibitor protein) suppresses invasion and metastasis)23. CRSP3 metastasis suppressor24. The suppressor function of TXNIP (Thioredoxin interacting protein-2)25. The essence of the Hippo signalling system26. HIC1 (hypermethylated in cancer 1) suppressor gene27. The DLC suppressor genes28. The LKB1 (STK11) suppressor gene29. PLCD1 (phospholipase Cδ1) suppresses tumorigenesis30. Inhibitor of DNA binding proteins (IDs) in tumours31. PDCD4 (Programmed Cell Death 4)

Epilogue

最近チェックした商品